Growing community of inventors

Berkeley, CA, United States of America

Andrew P Marcus

Average Co-Inventor Count = 9.56

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 100

Andrew P MarcusJulio Cesar Medina (5 patents)Andrew P MarcusMichael G Johnson (5 patents)Andrew P MarcusAn-Rong Li (5 patents)Andrew P MarcusJiwen Liu (4 patents)Andrew P MarcusXiaohui Du (3 patents)Andrew P MarcusXiaoqi Chen (3 patents)Andrew P MarcusJeffrey Thomas Mihalic (3 patents)Andrew P MarcusZice Fu (3 patents)Andrew P MarcusJason A Duquette (3 patents)Andrew P MarcusJeffrey Deignan (3 patents)Andrew P MarcusDarin J Gustin (3 patents)Andrew P MarcusPhilippe Bergeron (3 patents)Andrew P MarcusLiusheng Zhu (2 patents)Andrew P MarcusAlan X Huang (2 patents)Andrew P MarcusAndrew P Marcus (5 patents)Julio Cesar MedinaJulio Cesar Medina (73 patents)Michael G JohnsonMichael G Johnson (28 patents)An-Rong LiAn-Rong Li (15 patents)Jiwen LiuJiwen Liu (26 patents)Xiaohui DuXiaohui Du (47 patents)Xiaoqi ChenXiaoqi Chen (46 patents)Jeffrey Thomas MihalicJeffrey Thomas Mihalic (32 patents)Zice FuZice Fu (29 patents)Jason A DuquetteJason A Duquette (21 patents)Jeffrey DeignanJeffrey Deignan (19 patents)Darin J GustinDarin J Gustin (18 patents)Philippe BergeronPhilippe Bergeron (6 patents)Liusheng ZhuLiusheng Zhu (33 patents)Alan X HuangAlan X Huang (14 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Amgen Sf, LLC (4 from 5 patents)

2. Amgen Inc. (1 from 1,974 patents)


5 patents:

1. 7939538 - Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases

2. 7375102 - [object Object]

3. 7271271 - Imidazolo-related compounds, compositions and methods for their use

4. 7067662 - CXCR3 antagonists

5. 7053215 - Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/24/2025
Loading…